Definitive Contract HHSN261201200097C

Award Date 9/28/12
Potential Completion Date 6/26/15
Potential Value $1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fayetteville, AR 72764, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $299,999 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Ocean Nano TECH LLC, a woman-owned small disadvantaged business based in San Diego, California. The contract is for the development of a Quantum Dot Förster Resonance Energy Transfer (FRET) Immunoassay to quantify intramolecular epitopes of analytes in tissue sections, as part of the Small Business Innovation Research (SBIR) program....
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase II contract to Ocean Nano TECH LLC, a woman-owned small disadvantaged business, for the development of a quantum dot Förster resonance energy transfer (FRET) immunoassay to quantify intramolecular epitopes of analytes in tissue sections. The definitive, firm-fixed price contract has a potential value of $2,000,000.00 and a...
This is a $1,200,000.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Ocean Nano TECH LLC, a woman-owned small business. The contract is for the development of "target specific and drug loaded iron oxide nanoparticles for cancer imaging and therapy." This is a small business set-aside contract with a completion date of March 31, 2015. Ocean Nano TECH LLC is a provider of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small business. The contract, valued at $150,000.00, is for research and development related to the "TAS::75 0849::TAS" requirement. Ocean Nano TECH LLC is a provider of nanotechnology products and services, including for environmental testing and targeted...
The Department of Health and Human Services awarded a $199,993 Small Business Innovation Research (SBIR) Phase I contract to Ocean Nano TECH LLC, a woman-owned small disadvantaged business, for the development of "Target Specific and Drug Loaded Iron Oxide Nanoparticles for Cancer Imaging and Therapy." The contract, with a completion date of March 30, 2010, is a firm-fixed-price definitive contract. Ocean Nano TECH LLC has also received several federal grant awards and sub-awards to...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The $149,991 Firm Fixed Price contract supports research and development of biomedical nanotechnology products and services. The contract has a Total Small Business set-aside. According to the information provided, Ocean Nano TECH LLC has also received prior federal grant awards and sub-awards...
The U.S. government awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Evident Technologies, Inc., a small business located in Troy, NY. The $172,216.00 fixed-price contract is for the development of quantum dot nanotechnology to quantify marker expression in breast cancer. The contract was awarded on August 2, 2006 by a U.S. government agency, with a completion date of August 1, 2007. This SBIR Phase I contract is part of the agency's initiatives to support...
This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology...
<p>This contract was awarded by the National Cancer Institute, a civilian agency, to Nanoparticle Biochem, Inc., a for-profit organization and manufacturer of goods. The $998,293.57 cost-plus-fixed-fee contract is for the development of in vivo compatible and readily injectable gold nanoconstructs for tumor therapy. The contract was set aside for a small business and has an ultimate completion date of August 26, 2015.</p>
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Quantum Mark, LLC, a woman-owned small business. The $749,995.54 cost-plus-fixed-fee contract was awarded under the Small Business Innovation Research (SBIR) Phase II program to develop software systems to facilitate the use of electronic data records in the collection of population-based cancer surveillance data. The contract has a period of performance through June 29, 2012 and was set aside for...

This federal contract award was made by the National Cancer Institute to Ocean Nano TECH LLC, a woman-owned small business, to conduct research and development on multi-biomarker imaging using quantum dots for the prediction of HPV-associated cancers. The $1,000,000.00 cost-plus-fixed-fee contract does not have a set-aside designation. Ocean Nano TECH LLC has also received federal grant awards from the National Institutes of Health National Institute of Environmental Health Sciences for $185,847 and several federal sub-awards to provide nanotechnology-enabled imaging and targeted therapy applications for cancer treatment in partnership with Emory University. This contract supports the National Cancer Institute's biomedical research programs focused on developing novel imaging and therapeutic approaches for cancer.

Generated 11/24/24, 9:39 AM